Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 208

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Novel AAV serotypes for improved ocular gene transfer

Open access
Lebherz, Corinna, Maguire, Albert, Tang, Waixing, Bennett, Jean, Wilson, James M. · 2008 · The Journal of Gene Medicine

Abstract

Some of the most successful gene therapy results have been obtained using recombinant viral vectors to treat animal models of inherited and acquired ocular diseases. Clinical trials using adenovirus vector systems have been initiated for two ocular diseases. Adeno‐associated viruses (AAVs) represent an attractive alternative to adenoviral vector systems as they enable stable and long‐term expression and can target a variety of different ocular cell types depending on the capsid serotype; recently clinical trails for congenital blindness was initiated with a vector‐based AAV serotype 2. High levels of retinal gene transfer have been achieved using vectors based on AAV serotypes 1, 2, 4 and 5. This report compares the gene transfer efficacy and stability of expression of vector systems based on three novel AAV serotypes: AAV7, 8, 9, with the established vectors AAV1, 2, 5. We show here that AAV7 and 8 enable superior long‐term transduction of retinal and also anterior chamber structures. Copyright © 2008 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jgm.1126

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 40

  1. 10.1086/519025 · DOI · Paper page
  2. 10.1016/j.ymthe.2005.08.008 · DOI · Paper page
  3. 10.1016/j.ymthe.2003.11.013 · DOI · Paper page
  4. 10.1016/S0959-437X(03)00043-1 · DOI
  5. 10.1038/sj.gt.3302460 · DOI
  6. 10.1006/mthe.2000.0252 · DOI · Paper page
  7. 10.1038/sj.gt.3302030 · DOI · Paper page
  8. 10.1093/hmg/10.26.3075 · DOI · Paper page
  9. 10.1128/JVI.76.2.791-801.2002 · DOI · Paper page
  10. 10.1128/JVI.73.2.1309-1319.1999 · DOI · Paper page
  11. Chiorini JA, 1997, Cloning of adeno‐associated virus type 4 (AAV4) and generation of recombinant AAV4 particles, J Virol, 71, 6823, 10.1128/jvi.71.9.6823-6833.1997 · DOI · Paper page
  12. 10.1128/JVI.78.12.6381-6388.2004 · DOI · Paper page
  13. 10.1073/pnas.182412299 · DOI · Paper page
  14. 10.1099/0022-1317-81-8-2077 · DOI
  15. 10.1128/JVI.72.1.309-319.1998 · DOI · Paper page
  16. 10.1006/mthe.2001.0462 · DOI
  17. GaoG WilsonP.Purification of Recombinant Adeno‐Associated virus Vectorsby Column Chromatography and its performancein vivo. Hum Gene Ther2000;11:2079–2091. · DOI · Paper page
  18. Bennett J, 1997, Real‐time, noninvasive in vivo assessment of adeno‐associated virus‐mediated retinal transduction, Invest Ophthalmol Vis Sci, 38, 2857
  19. Hoffman LM, 1997, Cell‐mediated immune response and stability of intraocular transgene expression after adenovirus‐mediated delivery, Invest Ophthalmol Vis Sci, 38, 2224
  20. 10.1006/mthe.2000.0080 · DOI
  21. 10.1002/bies.1092 · DOI
  22. 10.1006/mthe.2002.0660 · DOI
  23. 10.1089/hum.2005.16.178 · DOI
  24. Chevez‐Barrios P, 2005, Immune response of retinoblastoma treated with suicide gene therapy using adenoviral‐mediated delivery of thymidine kinase followed by ganciclovir, Ft Lauderdale, FL, 5218
  25. Rasmussen H, 2001, Clinical protocol. An open‐label, phase I, single administration, dose‐escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age‐related macular degeneration (AMD), Hum Gene Ther, 12, 2029
  26. Behling K, 2002, AAV‐mediated retinal transfer of anti‐angiogenic genes in a murine model of retinopathy of prematurity (ROP), Invest Ophthalmol Vis Sci
  27. Duh EJ, 2002, Pigment epithelium‐derived factor suppresses ischemia‐induced retinal neovascularization and VEGF‐induced migration and growth, Invest Ophthalmol Vis Sci, 43, 821
  28. Mori K, 2002, AAV‐mediated gene transfer of pigment epithelium‐derived factor inhibits choroidal neovascularization, Invest Ophthalmol Vis Sci, 43, 1994
  29. Lau D, 2000, Retinal degeneration is slowed in transgenic rats by AAV‐mediated delivery of FGF‐2, Invest Ophthalmol Vis Sci, 41, 3622
  30. 10.1006/mthe.2001.0498 · DOI · Paper page
  31. 10.2165/00002512-200522040-00004 · doi:10.2165/00002512-200522040-00004
  32. 10.1093/hmg/ddi068 · DOI · Paper page
  33. 10.1126/science.275.5300.668 · DOI · Paper page
  34. Borras T, 1996, Ocular adenovirus gene transfer varies in efficiency and inflammatory response, Invest Ophthalmol Vis Sci, 37, 1282
  35. 10.1002/jgm.210 · DOI
  36. Borras T, 1998, Gene transfer to the human trabecular meshwork by anterior segment perfusion, Invest Ophthalmol Vis Sci, 39, 1503
  37. Budenz D, 1995, In vivo gene transfer into murine trabecular meshwork and corneal endothelial cells, Invest Ophthalmol Vis Sci, 36, 2211
  38. 10.1097/00003226-199601000-00006 · doi:10.1097/00003226-199601000-00006
  39. 10.1016/S0002-9394(98)00205-0 · doi:10.1016/s0002-9394(98)00205-0
  40. 10.1006/mthe.2001.0461 · DOI

Cited by

See all 208

Metadata

Authors
Lebherz, C., Maguire, A., Tang, W., Bennett, J., & Wilson, J. M.
Venue
The Journal of Gene Medicine
Publisher
Wiley
Published
2008-02-18
Volume
10
Issue
4
Pages
375-382
ISSN
  • 1099-498X (ISSN-L)
  • 1521-2254
OpenAlex
W2045031393
Cited by
208
References
2
FWCI
8.96
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Novel AAV serotypes for improved ocular gene transfer. https://app.cochat.ai/papers/10.1002/jgm.1126
The paper
Lebherz, C., Maguire, A., Tang, W., Bennett, J., & Wilson, J. M. (2008). Novel AAV serotypes for improved ocular gene transfer. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.1126

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.